Interest Expense in USD of Anebulo Pharmaceuticals, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Anebulo Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q3 2025.
  • Anebulo Pharmaceuticals, Inc. Interest Expense for the quarter ending September 30, 2025 was $17K, a 83% decline year-over-year.
  • Anebulo Pharmaceuticals, Inc. annual Interest Expense for 2025 was $400K, a 100% increase from 2024.
  • Anebulo Pharmaceuticals, Inc. annual Interest Expense for 2024 was $200K.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)

Anebulo Pharmaceuticals, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $17K -$83K -83% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q1 2025 $100K +$40.3K +67.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q3 2024 $100K Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q1 2024 $59.7K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $31.8K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q1 2021 $3.7K Jan 1, 2021 Mar 31, 2021 10-Q 2021-06-21
Q2 2020 $1.29K Apr 23, 2020 Jun 30, 2020 10-K 2021-09-22

Anebulo Pharmaceuticals, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $400K +$200K +100% Jul 1, 2024 Jun 30, 2025 10-K 2025-09-29
2024 $200K Jul 1, 2023 Jun 30, 2024 10-K 2025-09-29
2021 $11.8K Jul 1, 2020 Jun 30, 2021 10-K 2022-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.